
Carla J. Myers
Examiner (ID: 16755, Phone: (571)272-0747 , Office: P/1634 )
| Most Active Art Unit | 1634 |
| Art Unit(s) | 1634, 1621, 1655, 1644, 1643, 1807, 1654, 1682, 1609 |
| Total Applications | 2297 |
| Issued Applications | 991 |
| Pending Applications | 343 |
| Abandoned Applications | 982 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18280753
[patent_doc_number] => 20230096225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => CLINICAL PREDICTORS OF WEIGHT LOSS
[patent_app_type] => utility
[patent_app_number] => 17/581335
[patent_app_country] => US
[patent_app_date] => 2022-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26121
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17581335
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/581335 | CLINICAL PREDICTORS OF WEIGHT LOSS | Jan 20, 2022 | Abandoned |
Array
(
[id] => 17673147
[patent_doc_number] => 20220186314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => METHODS FOR DIAGNOSING AND TREATING INFLAMMATORY BOWEL DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/580357
[patent_app_country] => US
[patent_app_date] => 2022-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45483
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17580357
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/580357 | METHODS FOR DIAGNOSING AND TREATING INFLAMMATORY BOWEL DISEASE | Jan 19, 2022 | Abandoned |
Array
(
[id] => 17982976
[patent_doc_number] => 20220349012
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-03
[patent_title] => DNA METHYLATION DIAGNOSTIC TEST FOR BREAST CANCER
[patent_app_type] => utility
[patent_app_number] => 17/561434
[patent_app_country] => US
[patent_app_date] => 2021-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30023
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17561434
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/561434 | DNA METHYLATION DIAGNOSTIC TEST FOR BREAST CANCER | Dec 22, 2021 | Abandoned |
Array
(
[id] => 18972329
[patent_doc_number] => 20240052421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => METHOD OF IDENTIFYING AND TREATING MITOCHONDRIAL SUBTYPE TUMORS
[patent_app_type] => utility
[patent_app_number] => 18/259067
[patent_app_country] => US
[patent_app_date] => 2021-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23360
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -43
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18259067
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/259067 | METHOD OF IDENTIFYING AND TREATING MITOCHONDRIAL SUBTYPE TUMORS | Dec 21, 2021 | Pending |
Array
(
[id] => 17688216
[patent_doc_number] => 20220195508
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => tRNA-Derived Fragments as Disease Biomarkers and Neuropathological Regulators in Alzheimer's Disease
[patent_app_type] => utility
[patent_app_number] => 17/554782
[patent_app_country] => US
[patent_app_date] => 2021-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13947
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17554782
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/554782 | tRNA-Derived Fragments as Disease Biomarkers and Neuropathological Regulators in Alzheimer's Disease | Dec 16, 2021 | Pending |
Array
(
[id] => 17520796
[patent_doc_number] => 20220106645
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => Biomarkers for the Diagnosis of Lung Cancers
[patent_app_type] => utility
[patent_app_number] => 17/551113
[patent_app_country] => US
[patent_app_date] => 2021-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17036
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17551113
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/551113 | Biomarkers for the Diagnosis of Lung Cancers | Dec 13, 2021 | Abandoned |
Array
(
[id] => 19121242
[patent_doc_number] => 11965213
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-23
[patent_title] => Methods of detecting spatial heterogeneity of a biological sample
[patent_app_type] => utility
[patent_app_number] => 17/538406
[patent_app_country] => US
[patent_app_date] => 2021-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 52
[patent_no_of_words] => 104474
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 303
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17538406
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/538406 | Methods of detecting spatial heterogeneity of a biological sample | Nov 29, 2021 | Issued |
Array
(
[id] => 18879574
[patent_doc_number] => 20240002943
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => A METHOD FOR CLASSIFYING THE GUT INFLAMMATION STATUS IN AVIAN SPECIES
[patent_app_type] => utility
[patent_app_number] => 18/265029
[patent_app_country] => US
[patent_app_date] => 2021-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7399
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 150
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18265029
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/265029 | A METHOD FOR CLASSIFYING THE GUT INFLAMMATION STATUS IN AVIAN SPECIES | Nov 21, 2021 | Pending |
Array
(
[id] => 19826493
[patent_doc_number] => 12247259
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-11
[patent_title] => Using nucleic acid size range for noninvasive cancer detection
[patent_app_type] => utility
[patent_app_number] => 17/521333
[patent_app_country] => US
[patent_app_date] => 2021-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 24
[patent_no_of_words] => 21654
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 230
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17521333
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/521333 | Using nucleic acid size range for noninvasive cancer detection | Nov 7, 2021 | Issued |
Array
(
[id] => 18955601
[patent_doc_number] => 20240043928
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => BIOMARKERS FOR MYELODYSPLASTIC SYNDROME (MDS) AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/034859
[patent_app_country] => US
[patent_app_date] => 2021-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23917
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -66
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18034859
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/034859 | BIOMARKERS FOR MYELODYSPLASTIC SYNDROME (MDS) AND METHODS OF USING THE SAME | Nov 2, 2021 | Pending |
Array
(
[id] => 17414415
[patent_doc_number] => 20220049319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => METHODS FOR DETECTING AND TREATING PROPRANOLOL SENSITIVE TUMORS
[patent_app_type] => utility
[patent_app_number] => 17/513279
[patent_app_country] => US
[patent_app_date] => 2021-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14003
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17513279
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/513279 | Methods for detecting and treating propranolol sensitive tumors | Oct 27, 2021 | Issued |
Array
(
[id] => 18903107
[patent_doc_number] => 20240018592
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => METHODS OF ASSESSING THE THERAPEUTIC ACTIVITY OF AGENTS FOR THE TREATMENT OF IMMUNE DISORDERS
[patent_app_type] => utility
[patent_app_number] => 18/033582
[patent_app_country] => US
[patent_app_date] => 2021-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22869
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18033582
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/033582 | METHODS OF ASSESSING THE THERAPEUTIC ACTIVITY OF AGENTS FOR THE TREATMENT OF IMMUNE DISORDERS | Oct 25, 2021 | Pending |
Array
(
[id] => 17402673
[patent_doc_number] => 20220044764
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => TREATMENT OF CANCER BY RISK STRATIFICATION OF PATIENTS BASED ON COMORDIDITIES
[patent_app_type] => utility
[patent_app_number] => 17/451482
[patent_app_country] => US
[patent_app_date] => 2021-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13940
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17451482
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/451482 | TREATMENT OF CANCER BY RISK STRATIFICATION OF PATIENTS BASED ON COMORDIDITIES | Oct 18, 2021 | Abandoned |
Array
(
[id] => 17367697
[patent_doc_number] => 20220022749
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => ALZHEIMER'S DISEASE PERSONALIZED MEDICINE
[patent_app_type] => utility
[patent_app_number] => 17/499060
[patent_app_country] => US
[patent_app_date] => 2021-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25652
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17499060
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/499060 | ALZHEIMER'S DISEASE PERSONALIZED MEDICINE | Oct 11, 2021 | Abandoned |
Array
(
[id] => 18786465
[patent_doc_number] => 20230374591
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-23
[patent_title] => METHODS AND AGENTS FOR TREATING, PREVENTING, DIAGNOSING, AND EVALUATING THERAPY FOR FIBROTIC, AUTOIMMUNE, AND INFLAMMATORY CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 18/030801
[patent_app_country] => US
[patent_app_date] => 2021-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18889
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18030801
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/030801 | METHODS AND AGENTS FOR TREATING, PREVENTING, DIAGNOSING, AND EVALUATING THERAPY FOR FIBROTIC, AUTOIMMUNE, AND INFLAMMATORY CONDITIONS | Oct 6, 2021 | Pending |
Array
(
[id] => 17705037
[patent_doc_number] => 20220205043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => DETECTING CANCER RISK
[patent_app_type] => utility
[patent_app_number] => 17/493826
[patent_app_country] => US
[patent_app_date] => 2021-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24722
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17493826
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/493826 | Detecting cancer risk | Oct 3, 2021 | Issued |
Array
(
[id] => 18270796
[patent_doc_number] => 20230092038
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => DRAIN FLUID FOR DIAGNOSTICS
[patent_app_type] => utility
[patent_app_number] => 17/491237
[patent_app_country] => US
[patent_app_date] => 2021-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4216
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17491237
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/491237 | Drain fluid for diagnostics | Sep 29, 2021 | Issued |
Array
(
[id] => 17444212
[patent_doc_number] => 20220064717
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => RNA Printing and Sequencing Devices, Methods, and Systems
[patent_app_type] => utility
[patent_app_number] => 17/480839
[patent_app_country] => US
[patent_app_date] => 2021-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15986
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17480839
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/480839 | RNA Printing and Sequencing Devices, Methods, and Systems | Sep 20, 2021 | Pending |
Array
(
[id] => 19676244
[patent_doc_number] => 12188095
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-07
[patent_title] => Methods and compositions for identifying and treating patients with small cell lung cancer
[patent_app_type] => utility
[patent_app_number] => 17/479701
[patent_app_country] => US
[patent_app_date] => 2021-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 60
[patent_figures_cnt] => 98
[patent_no_of_words] => 28688
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 192
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17479701
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/479701 | Methods and compositions for identifying and treating patients with small cell lung cancer | Sep 19, 2021 | Issued |
Array
(
[id] => 18895612
[patent_doc_number] => 20240011097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => COMPOSITION FOR DIAGNOSIS OR PREDICTION OF METABOLIC SYNDROME OR GROUP AT HIGH RISK OF EXPRESSION OF BLOOD CERAMIDE
[patent_app_type] => utility
[patent_app_number] => 18/248133
[patent_app_country] => US
[patent_app_date] => 2021-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9368
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18248133
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/248133 | COMPOSITION FOR DIAGNOSIS OR PREDICTION OF METABOLIC SYNDROME OR GROUP AT HIGH RISK OF EXPRESSION OF BLOOD CERAMIDE | Sep 15, 2021 | Pending |